Collins: Relative Strength Favorites

09/26/2003 12:00 am EST


Jim Collins

Chairman and CEO, Insight Capital Research & Management, Inc.

The Hulbert Financial Digest recently reviewed newsletter performance since the crash of 1987. At the top of the list was OTC Insight, edited by Jim Collins. The service scored a 16.6% average annual gain over the subsequent 16-year period. Here’s his latest buys.

"The following stocks are exceptionally attractive. However, we caution that they are most appropriate for aggressive traders. Both issues have relative strength ratings of 99, which means that they are outperforming 99 out of every 100 stocks.

"Flamel (FLML NASDAQ) is a biopharmaceutical company engaged in unique drug delivery technologies. It has developed the Micropump, for the administration of small molecules. Through this microparticle technology, the delivery of drugs can be more carefully regulated. Its Medusa product uses nanoparticles to control the release of native proteins over a long period of time. The company has several agreements to develop this technology for the treatment of Hepatitis B and C, and some cancers; its technology was also licensed to Bristol-Myers Squib for the treatment of diabetes. The stock recently reached an all-time.

"Mobility Electronics (MOBE NASDAQ) provides a broad range of solutions for the mobile-electronics user. Its Juice power adapter products allow mobile-device users to operate and charge their devices in a vehicle, airplane,  home or office. Its Quickoffice software provides users of handheld devices to edit with Microsoft Word, PowerPoint and Excel. We caution that the company has yet to turn a profit. In the quarter ended June 30, the firm reported a loss of 7 cents a share (vs. a loss of 19 cents in the year earlier period) while revenues increased 96%. The stock reached a multi-year high in July, pulled back about 25% and has since moved back up to its highs."

  By clicking submit, you agree to our privacy policy & terms of service.

Related Articles on